[ Pharmaceutical Sciences Asia - ONLINE ]
E-ISSN 2586-8470
[ Journal Abbreviation: Pharm.Sci.Asia ]
Mahidol University Journal of Pharmaceutical Sciences
  FORMER NAME   "Mahidol University Journal of Pharmaceutical Sciences" Published Since 1974

 
Abstracts

DOI: 10.29090/psa.2022.01.21.119Pharm Sci Asia 2022; 49(1), 98-105
 

Tolvaptan response predictors in acute heart failure patients with congestion

Hindun Wilda Risni1, Rani Sauriasari1*, Oriza Satifa2

1 Faculty of Pharmacy, Universitas Indonesia, Depok, Indonesia
2 Pharmacy Department, Harapan Kita National Heart Center, Jakarta, Indonesia


Tolvaptan has been used in many countries as an adjunct to diuretic therapy for heart failure. The identification of predictors of response to tolvaptan is essential in developing individual treatment plans, and this study therefore aims to identify responders and predictors to the use of this treatment. A total of 75 acute heart failure patients with congestion receiving tolvaptan were analyzed retrospectively. Clinical parameters after tolvaptan treatment were evaluated to provide an overview of the effectiveness and safety of tolvaptan. A predictive model was created, and logistic regression analysis was performed. The criterion for diuresis response was peak fluid balance of >-1000 ml, while the criterion for sodium response was >3.5 mEq/l sodium increase. Clinical parameters of urine volume and fluid balance before and after tolvaptan did not differ significantly, but serum creatinine, eGFR, sodium, potassium, and blood pressure were significantly different. Hypernatremia occurred in one patient. Multivariate analysis of all samples showed that diabetes (OR=4.856; P=0.006) and systolic blood pressure (SBP) (OR=1.031; P=0.046) affected diuresis response. Analysis in hyponatremic patients demonstrated that sex (OR=0.159; P=0.033) and serum sodium (OR=0.83; P=0.045) affected sodium response. Administration of tolvaptan significantly changed serum creatinine, eGFR, sodium, potassium, and blood pressure. The predictors for diuresis responders were the absence of type 2 diabetes and having higher baseline SBP, while the predictors for sodium responders were being male and having lower baseline serum sodium levels.


Keyword:

Heart failure, Diuresis response, Sodium response, Tolvaptan




Download full paper (PDF File size: 969.85 KB.)





Vol.49
No.6
November-December 2022

See other volume

 


Vol.49
No.5
September-October 2022

See other volume

 


Vol.49
No.4
July-August 2022

See other volume

 


Vol.49
No.3
May-June 2022

See other volume

 


Vol.49
No.2
March-April 2022

See other volume

 


Vol.49
No.1
January-February 2022

See other volume

 
 
 

Home
Aims and Scope
Editorial Board
Publication Ethics
Instruction to Authors
Announcement
All Volumes & Issues
Submit Online
Contact us
   
Search
   
Faculty of Pharmacy Mahidol University
Mahidol University



Pharmaceutical Sciences Asia by Faculty of Pharmacy, Mahidol University, Thailand is licensed under CC BY-NC-ND 4.0

    Copyright © 2017-2024
    Faculty of Pharmacy, Mahidol University, THAILAND
 

We use Cookies

This site uses cookies to personalise your experience and analyse site traffic. By Clicking ACCEPT or continuing to browse the site you are agreeing to our use of cookies.